Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Oncotargets and Therapy|May 31, 2018
High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patientsPablo Mandó, Manglio Rizzo, María Paula Roberti, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2023
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patientsMaría B Bordignon, Ayelén I Pesce Viglietti, Estefanía P Juliá, et al.
JCO Global Oncology|November 27, 2024
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database AnalysisPablo Mandó, Verónica Fabiano, Soledad Gomez Guasch, et al.
Journal of Breast Cancer|July 11, 2017
High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast CancersPablo Mandó, Manglio Rizzo, Constanza Perez de la Puente, et al.
JCO Global Oncology|December 4, 2025
Challenges and Opportunities for Cancer Clinical Trials Development in Latin AmericaJuan Manuel Garzón-Dangond, Oscar Arrieta, Pablo Mandó, et al.
International Journal of Molecular Sciences|September 14, 2024
In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus PertuzumabAyelén Ivana Pesce Viglietti, María Belén Bordignon, Alexis Ostinelli, et al.
JCO Global Oncology|September 20, 2024
Determining Clinicopathologic Factors That Influence Treatment in Advanced Breast Cancer in Argentina After CDK4/6 InhibitorsFederico Waisberg, Pablo Mandó, Carolina Almada, et al.
Therapeutic Advances in Medical Oncology|October 22, 2025
Physician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American surveyDana Narvaez, Federico Waisberg, Cynthia Villarreal-Garza, et al.
Medicina|June 27, 2025
Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancerMartín Abba, Fariba Behbod, Paolo Ceppi, et al.
NPJ Breast Cancer|June 2, 2026
Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohortMonique Celeste Tavares, Flávia C Balint, Romualdo Barroso-Sousa, et al.
Pageof 3